Daix (France), New York City (New York, United States), July 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), today announced the results of the votes of its Combined Shareholders' Meeting.
The Combined Shareholders' Meeting was held on Tuesday June 30, 2026, at 2 p.m. at Hôtel Villa M, 24-30 Bd Pasteur, 75015 Paris (France), under the chairmanship of Mr. Andrew Obenshain, Chief Executive Officer of Inventiva.
Mr. Andrew Obenshain proceeded to the usual formalities of the opening of the meeting, in particular to the constitution of the Bureau by appointing Mrs Susan Coles and Mr. Jean Volatier, as tellers, as well as Mr. Abel Colomb, as secretary of the general meeting.
All the resolutions submitted to vote have been adopted by the shareholders, with the exception of the 31st resolution, which had been the subject of a negative recommendation by the Board of Directors. The 31st resolution would have empowered the Board of Directors to decide on share capital increases reserved for members of a company savings plan to be set up by the Company.
Pursuant to Article R. 22-10-14 IV. of the French Commercial Code, the Combined Shareholders' Meeting approved, without modification, the compensation policy for corporate officers as presented in the 2025 Universal Registration Document (section 3.5.1, pages 134 et seq.) and, with respect specifically to the chairman of the board of directors, in the notice of meeting (brochure de convocation) for the Combined General Meeting, made available on the Company's website under the "General Meetings" section.
The results of the vote are presented below:
Total number of shares composing the share capital: 236 280 202
Total number of shares with voting rights: 236 280 202
|
ORDINARY PART |
EXTRAORDINARY PART | ||||
|
Shareholders |
Shares |
Votes |
Shareholders |
Shares |
Votes |
Shareholders Present |
5 |
318 490 |
519 790 |
5 |
318 490 |
519 790 |
Proxy To Third Parties |
0 |
0 |
0 |
0 |
0 |
0 |
Proxy To The Chairman |
214 |
21 380 077 |
21 505 444 |
214 |
21 380 077 |
21 505 444 |
Mail Votes |
221 |
148 125 573 |
155 342 788 |
221 |
148 125 573 |
155 342 788 |
TOTAL |
440 |
169 824 140 |
177 368 022 |
440 |
169 824 140 |
177 368 022 |
QUORUM |
71,874 % |
71,874 % |
VOTE RESULTS: Ordinary Resolutions
Resolution |
Results |
For |
Against |
Abstention |
Total votes taken into account |
Total number of votes cast |
Proportion of represented share capital |
Non- voting votes |
Invalid votes |
Quorum | |||
Votes |
% |
Votes |
% |
Votes |
% | ||||||||
1 |
Adopted |
177 222 228 |
99,92 % |
133 103 |
0,08 % |
12 691 |
- |
177 355 331 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
2 |
Adopted |
177 221 334 |
99,92 % |
134 197 |
0,08 % |
12 491 |
- |
177 355 531 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
3 |
Adopted |
177 221 057 |
99,92 % |
134 109 |
0,08 % |
12 856 |
- |
177 355 166 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
4 |
Adopted |
177 218 663 |
99,92 % |
138 566 |
0,08 % |
10 793 |
- |
177 357 229 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
5 |
Adopted |
169 001 759 |
99,80 % |
333 429 |
0,20 % |
8 475 |
- |
169 335 188 |
161 799 781 |
68,477 % |
8 024 359 |
0 |
71,874 % |
6 |
Adopted |
142 101 931 |
80,13 % |
35 235 606 |
19,87 % |
30 485 |
- |
177 337 537 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
7 |
Adopted |
142 260 329 |
80,22 % |
35 075 808 |
19,78 % |
31 885 |
- |
177 336 137 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
8 |
Adopted |
142 242 043 |
80,21 % |
35 094 119 |
19,79 % |
31 860 |
- |
177 336 162 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
9 |
Adopted |
142 260 377 |
80,22 % |
35 075 785 |
19,78 % |
31 860 |
- |
177 336 162 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
10 |
Adopted |
171 116 568 |
96,49 % |
6 233 151 |
3,51 % |
18 303 |
- |
177 349 719 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
11 |
Adopted |
142 115 577 |
80,14 % |
35 219 585 |
19,86 % |
32 860 |
- |
177 335 162 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
12 |
Adopted |
142 256 741 |
80,22 % |
35 077 573 |
19,78 % |
33 708 |
- |
177 334 314 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
13 |
Adopted |
143 403 465 |
80,86 % |
33 943 220 |
19,14 % |
21 337 |
- |
177 346 685 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
14 |
Adopted |
170 745 845 |
96,28 % |
6 604 810 |
3,72 % |
17 367 |
- |
177 350 655 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
15 |
Adopted |
172 576 402 |
97,31 % |
4 763 296 |
2,69 % |
28 324 |
- |
177 339 698 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
16 |
Adopted |
174 294 992 |
98,28 % |
3 044 831 |
1,72 % |
28 199 |
- |
177 339 823 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
17 |
Adopted |
151 354 591 |
85,35 % |
25 987 080 |
14,65 % |
26 351 |
- |
177 341 671 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
18 |
Adopted |
151 353 927 |
85,35 % |
25 987 714 |
14,65 % |
26 381 |
- |
177 341 641 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
19 |
Adopted |
151 170 758 |
85,24 % |
26 170 883 |
14,76 % |
26 381 |
- |
177 341 641 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
20 |
Adopted |
145 764 550 |
82,20 % |
31 566 386 |
17,80 % |
37 086 |
- |
177 330 936 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |
40 |
Adopted |
177 215 321 |
99,93 % |
127 471 |
0,07 % |
25 230 |
- |
177 342 792 |
169 824 140 |
71,874 % |
0 |
0 |
71,874 % |